January 31, 2025 - 19:35

The White House has plunged much of the government’s health-care apparatus into disarray, raising concerns among advocates and experts alike. This approach, characterized by rapid policy changes and a lack of cohesive strategy, has left many questioning the future of health care in the country.
The administration's decisions have led to significant disruptions in programs designed to provide essential services to millions of Americans. As funding cuts and regulatory rollbacks take effect, vulnerable populations are at risk of losing access to necessary medical care. Health care providers are also feeling the strain, grappling with uncertainty in funding and policy frameworks that affect their ability to deliver services effectively.
Critics argue that this slash-and-burn tactic could exacerbate existing health disparities and lead to a rise in preventable illnesses. As the administration continues to pursue its agenda, the long-term implications for the health care system remain unclear, prompting urgent calls for a more stable and inclusive approach to health care policy.
June 25, 2026 - 03:04
Houston Methodist receives $110M donation, largest in health system’s historyHouston Methodist has received a $110 million gift from The Brockman Medical Research Foundation, marking the largest single donation in the health system`s history. The funds are designated to...
June 24, 2026 - 07:18
Reproductive Health and Constitutionalism in Latin America: A Research AgendaVeronica Undurraga, a professor at the Faculty of Law of Universidad Adolfo Ibanez, has put forward a new research agenda examining the intersection of reproductive health and constitutionalism...
June 23, 2026 - 21:10
Trump administration charges 455 people, including doctors, with $6.5 billion in healthcare fraudThe Justice Department announced charges on Tuesday against 455 individuals, including dozens of doctors, for their alleged roles in healthcare fraud schemes and opioid abuse totaling 6.5 billion...
June 23, 2026 - 04:50
Federal health agencies unveil plan to speed up phase 1 clinical trials by 6 to 12 monthsAs the biotech industry gathers in San Diego for the BIO International Convention, the Department of Health and Human Services has released a series of initiatives aimed at accelerating early-stage...